Rivaroxaban for the prevention of venous thromboembolism after radiofrequency ablation of saphenous veins concomitant with miniphlebectomy, sclerotherapy, or no treatment of varicose tributaries.
Elena MurzinaKirill V LobastovLeonid LaberkoAnton DvornikovIvan PopovPublished in: Phlebology (2021)
Once-daily 10 mg rivaroxaban is suitable for VTE prophylaxis after RFA of saphenous veins.